A detailed history of Factory Mutual Insurance CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Factory Mutual Insurance CO holds 6,000 shares of GILD stock, worth $551,280. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$551,280
Previous $411,000 22.14%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$64.88 - $73.64 $20.6 Million - $23.4 Million
-317,935 Reduced 98.15%
6,000 $409,000
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $900,277 - $971,299
13,300 Added 4.28%
323,935 $22.6 Million
Q2 2021

Jul 14, 2021

SELL
$63.47 - $69.35 $630,447 - $688,853
-9,933 Reduced 3.1%
310,635 $21.4 Million
Q1 2021

May 10, 2021

SELL
$60.0 - $68.46 $331,920 - $378,720
-5,532 Reduced 1.7%
320,568 $20.7 Million
Q4 2020

Feb 17, 2021

BUY
$56.65 - $64.55 $1.73 Million - $1.98 Million
30,600 Added 10.36%
326,100 $19 Million
Q2 2020

Jul 13, 2020

SELL
$72.34 - $84.0 $33.4 Million - $38.7 Million
-461,300 Reduced 60.95%
295,500 $22.7 Million
Q1 2020

Apr 16, 2020

SELL
$62.63 - $80.22 $10.9 Million - $13.9 Million
-173,700 Reduced 18.67%
756,800 $56.6 Million
Q1 2019

Apr 09, 2019

BUY
$62.53 - $70.05 $23.3 Million - $26.1 Million
372,900 Added 66.88%
930,500 $63 Million
Q3 2018

Oct 10, 2018

BUY
$71.28 - $78.92 $1.02 Million - $1.13 Million
14,300 Added 2.63%
557,600 $43.1 Million
Q2 2018

Jul 19, 2018

BUY
$64.88 - $75.68 $285,472 - $332,992
4,400 Added 0.82%
543,300 $38.5 Million
Q1 2018

Apr 05, 2018

SELL
$72.84 - $88.8 $3.64 Million - $4.44 Million
-50,000 Reduced 8.49%
538,900 $40.6 Million
Q3 2017

Oct 11, 2017

BUY
$72.11 - $85.47 $42.5 Million - $50.3 Million
588,900
588,900 $47.7 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Factory Mutual Insurance CO Portfolio

Follow Factory Mutual Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factory Mutual Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Factory Mutual Insurance CO with notifications on news.